132 related articles for article (PubMed ID: 38574222)
1. ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
Espinosa K
Am Fam Physician; 2024 Mar; 109(3):275-276. PubMed ID: 38574222
[No Abstract] [Full Text] [Related]
2. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
3. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
4. Colposcopy for cervical screening in low-resource settings.
de Sanjose S
Lancet Glob Health; 2023 Mar; 11(3):e304-e305. PubMed ID: 36796965
[No Abstract] [Full Text] [Related]
5. Testing for cervical cancer: new recommendations from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology.
CA Cancer J Clin; 2012; 62(3):211-2. PubMed ID: 22418892
[No Abstract] [Full Text] [Related]
6. Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China.
Gui T; Chen Z; Chen F
PLoS One; 2021; 16(7):e0253493. PubMed ID: 34197472
[TBL] [Abstract][Full Text] [Related]
7. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
8. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RL; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya G; Wentzensen N; Schiffman M
J Low Genit Tract Dis; 2020 Oct; 24(4):426. PubMed ID: 32732648
[No Abstract] [Full Text] [Related]
9. Considerations to inform minimum slide numbers to maintain cytology triage screening competencies.
Nuttall D
Cytopathology; 2022 Nov; 33(6):746-748. PubMed ID: 35864602
[No Abstract] [Full Text] [Related]
10. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and cervical disease in adolescents.
Guido R
Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
[TBL] [Abstract][Full Text] [Related]
12. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
[No Abstract] [Full Text] [Related]
13. Colposcopy, cervical screening, and HPV. Preface.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
[No Abstract] [Full Text] [Related]
14. 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2024 Jan; 28(1):3-6. PubMed ID: 38117563
[TBL] [Abstract][Full Text] [Related]
15. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.
Nayar R; Chhieng DC; Crothers B; Darragh TM; Davey DD; Eisenhut C; Goulart R; Huang EC; Tabbara SO
J Am Soc Cytopathol; 2020; 9(4):291-303. PubMed ID: 32565297
[TBL] [Abstract][Full Text] [Related]
16. Cervical Cancer Screening with HPV Testing: Updates on the Recommendation.
Carvalho CF; Teixeira JC; Bragança JF; Derchain S; Zeferino LC; Vale DB
Rev Bras Ginecol Obstet; 2022 Mar; 44(3):264-271. PubMed ID: 35170010
[TBL] [Abstract][Full Text] [Related]
17. Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
Sookaromdee P; Wiwanitkit V
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1020-S1021. PubMed ID: 38384106
[No Abstract] [Full Text] [Related]
18. [The role of colposcopy in Population Program of Cervical Cancer Early Detection].
Wojciech R
Ginekol Pol; 2007 Sep; 78(9):719-22. PubMed ID: 18159827
[TBL] [Abstract][Full Text] [Related]
19. Implementing HPV Testing for Colposcopy Patients in a Regional Centre.
Yang Q; Di Cecco R; McRae S; McLachlin CM
J Obstet Gynaecol Can; 2021 May; 43(5):555-556. PubMed ID: 33992127
[No Abstract] [Full Text] [Related]
20. European consensus statement on essential colposcopy.
Redman CWE; Kesic V; Cruickshank ME; Gultekin M; Carcopino X; Castro Sanchez M; Grigore M; Jakobsson M; Kuppers V; Pedro A; Reich O; Leeson S; Tabuica U; Zodzika J; Ciavattini A; Jach R; Katsyuba M; Koiss R; Martin-Hirsch P; Tjalma WA; Nieminen P;
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():57-62. PubMed ID: 33171418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
